Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 235

Results For "INST"

3134 News Found

Thyssenkrupp bags order for a pharma-grade SFE plant for solids extraction
News | March 23, 2022

Thyssenkrupp bags order for a pharma-grade SFE plant for solids extraction

The scope of supply includes the skid-mounted plant as well as on-site installation and commissioning support


Covovax for teens get DCGI nod
Drug Approval | March 23, 2022

Covovax for teens get DCGI nod

It is the fourth vaccine to get the nod for 12 years and older after Biological E’s Corbevax, Bharat Biotech’s Covaxin and Zydus Lifesciences Zy-CoV-D


Waters introduces  automated solutions for mass and purity analysis of biomolecules
Biotech | March 23, 2022

Waters introduces automated solutions for mass and purity analysis of biomolecules

New line of Waters MaxPeak Premier columns further enhances the analysis by delivering 2x to 3x greater sensitivity than conventional steel columns


Venus Remedies aims to achieve Rs 1000 crore turnover by 2025: Saransh Chaudhary, President, Global Critical Care Division, Venus Remedies and CEO, Venus Medicine Research Centre
interviews | March 22, 2022

Venus Remedies aims to achieve Rs 1000 crore turnover by 2025: Saransh Chaudhary, President, Global Critical Care Division, Venus Remedies and CEO, Venus Medicine Research Centre

Saransh Chaudhary, President, Global Critical Care Division, Venus Remedies and CEO, Venus Medicine Research Centre In conversation with Thomas C Thottathil, Editor, www.indianpharmapost.com identified key areas that the company is focusing on in its Mission 2025


Milltrust Ventures to invest in Oncoshot
Startup | March 22, 2022

Milltrust Ventures to invest in Oncoshot

Milltrust Ventures will also assist Oncoshot with its expansion in Australia and India, where the latter has already established partnerships amongst apex cancer institutes


Mandaviya launches BRICS vaccine R&D centre
Policy | March 22, 2022

Mandaviya launches BRICS vaccine R&D centre

The Centre will be instrumental in streamlining vaccination resources and facilitate equitable access to safe and efficacious COVID-19 vaccines


Merck’s Keytruda approved for fourth gynecologic cancer indication
Drug Approval | March 22, 2022

Merck’s Keytruda approved for fourth gynecologic cancer indication

The approval is based on new data from cohorts D and K of the KEYNOTE-158 trial


Kypros Nicolaides Fetal Medicine centre opens in Abu Dhabi
Hospitals | March 22, 2022

Kypros Nicolaides Fetal Medicine centre opens in Abu Dhabi

Prof. Kypros has revolutionised the field of fetal medicine through his extensive research and medical practice achievements, including introducing intrauterine blood transfusions for fetal anaemia


NIBIOHN identifies tissue-specific exosome marker candidates from blood
Biotech | March 22, 2022

NIBIOHN identifies tissue-specific exosome marker candidates from blood

Blood contains a mixture of exosomes secreted from nearly all tissues and cells, and exosomes from other tissues can mask changes caused by disease, making it difficult to detect the presence of biomarkers that reflect disease


Intravacc publishes a GMP process for a semi-synthetic Shigella glycoconjugate vaccine
Biotech | March 22, 2022

Intravacc publishes a GMP process for a semi-synthetic Shigella glycoconjugate vaccine

Data published in the prestigious journal ACS Central Science of the American Chemical Society